The potential role of adipokines and hepatokines in age-related ocular diseases

The potential role of adipokines and hepatokines in age-related ocular diseases

Age-related ocular diseases, including diabetic retinopathy (DR), age-related macular degeneration (AMD), cataract and glaucoma may lead to visual impairment and even to blindness. Metabolic diseases, such as obesity and metabolic dysfunction-associated steatotic liver disease (MASLD) have emerged a...

Full description

Saved in:

Bibliographic Details
Main Authors:	Stavroula Almpanidou, Ilias D. Vachliotis, Antonis Goulas, Stergios A. Polyzos
Format:	Article
Language:	English
Published:	Elsevier 2025-06-01
Series:	Metabolism Open
Subjects:	Ocular disease Adipokines Obesity Hepatokines Metabolic dysfunction-associated steatotic liver disease Nonalcoholic fatty liver disease
Online Access:	http://www.sciencedirect.com/science/article/pii/S2589936825000210
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Retinopathy in Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Myrsini Orfanidou, et al.
Published: (2024-12-01)

Unmet needs of metabolic dysfunction – Associated “fatty or steatotic” liver disease
by: Yu-Ming Cheng, et al.
Published: (2025-04-01)

Hepatokine and Proinflammatory Cytokine Profile in Patients with Carotid Atherosclerosis and Metabolic Dysfunction-Associated Steatotic Liver Disease
by: Ana Delfina Cano-Contreras, et al.
Published: (2025-04-01)

Age-specific protective effects of statins against cirrhosis in patients with chronic liver enzyme elevation associated with metabolic dysfunction: a retrospective cohort study of electronic health recordsResearch in context
by: Ayako Suzuki, et al.
Published: (2025-09-01)

FLI and FIB-4 in diagnosing metabolic dysfunction-associated steatotic liver disease in primary care: High prevalence and risk of significant disease
by: Mário Reis Álvares-da-Silva, et al.
Published: (2025-01-01)

Low-carbohydrate diets reduce cardiovascular risk factor levels in patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis of randomized controlled trials
by: Shanshan Pi, et al.
Published: (2025-08-01)

The impact of fasting on cardiovascular risk control in patients with metabolic dysfunction-associated steatotic liver disease
by: Anna E. Płatek, et al.
Published: (2023-09-01)

The impact of serum neuregulin 4 (NRG-4) levels on non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis
by: Mohammad Amin Tapak, et al.
Published: (2025-07-01)

Metabolic Dysfunction–Associated Steatotic Liver Disease, Alcohol Consumption, and the Risk of Atrial Fibrillation: A Nationwide Population‐Based Study
by: Minkwan Kim, et al.
Published: (2025-07-01)

Brain-acting hepatokines: its impact on energy balance and metabolism
by: Lucía Giovanini, et al.
Published: (2025-05-01)

Metabolic dysfunction-associated steatotic liver disease (MASLD) in children with obesity: An Obesity Medicine Association (OMA) and expert joint perspective 2025
by: Jennifer Panganiban, et al.
Published: (2025-06-01)

Circulating Proteomics Identifies a Dynamic Profile of Hepatic Steatosis During Metabolic Intervention
by: Bassim El‐Sabawi, et al.
Published: (2025-05-01)

Steatotic Liver Disease: New Nomenclature and Its Localization in the Russian Federation
by: K. L. Raikhelson, et al.
Published: (2024-05-01)

Hyperinsulinemic male LEW.1WR1 rats show early signs of impaired liver metabolism
by: Madushika Wimalarathne, et al.
Published: (2025-03-01)

In vitro antioxidant effects and in vivo hepatoprotective effects of Osbeckia octandra, Vernonia cinerea and Atalantia ceylanica on a high fat diet induced metabolic dysfunction-associated steatotic liver disease mouse model
by: Anuththara Upamali Abeykoon, et al.
Published: (2025-05-01)

MASLD vs. MAFLD. A narrative review
by: Amedeo Lonardo, et al.
Published: (2025-08-01)

Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021
by: Gong Feng, et al.
Published: (2025-03-01)

Mediation Analyses Link Cardiometabolic Factors and Liver Fat With White Matter Hyperintensities and Cognitive Performance: A UK Biobank Study
by: Daniel E. Askeland-Gjerde, et al.
Published: (2025-07-01)

Beyond Nonalcoholic Fatty Liver Disease: The Expansive Realm of Metabolic Dysfunction-associated Steatotic Liver Disease
by: Samir Samadarshi, et al.
Published: (2025-01-01)

Association of uric acid levels with the development of metabolic dysfunction-associated and metabolic and alcohol-related/associated steatotic liver disease: a study on Japanese participants undergoing health checkups
by: Tatsuya Fukuda, et al.
Published: (2025-06-01)

Metabolic associated steatotic liver disease misses fewer high-risk patients than metabolic associated fatty liver disease
by: Yu-Ming Cheng, et al.
Published: (2024-12-01)

Exploring the epidemiology and awareness of metabolic dysfunction-associated steatotic liver disease (MASLD) among health sciences students in an academic health care institute in India
by: Umasankari S., et al.
Published: (2024-12-01)

Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
by: Xianhua Mao, et al.
Published: (2025-07-01)

Transitioning from NAFLD to MAFLD and MASLD: the toxic relationship with alcohol consumption
by: Mubin Ozercan, et al.
Published: (2025-01-01)

Clinical characteristics of lean metabolic-associated fatty liver disease and the impact of concurrent diabetes mellitus
by: Yu-Ming Cheng, et al.
Published: (2024-09-01)

Circulating angiopoietin-like protein 8 (ANGPTL8) and steatotic liver disease related to metabolic dysfunction: an updated systematic review and meta-analysis
by: Farah Abdelhameed, et al.
Published: (2025-04-01)

The evolution of international definitions of fatty liver disease and insights into the working definition and features of the 2024 Chinese guideline
by: Li CHEN, et al.
Published: (2025-06-01)

Comparison of the effects of pemafibrate and omega-3 fatty acid ethyl on fatty liver index in patients with dyslipidemia treated with statin: a sub-analysis from the PROUD48 study
by: Yasutaka Takeda, et al.
Published: (2025-05-01)

Associations of Metabolic Dysfunction–Associated Fatty Liver Disease With Peripheral Artery Disease: Prospective Analysis in the UK Biobank and ARIC Study
by: YueRuiJing Liu, et al.
Published: (2024-11-01)

The Role of the Liver in the Pathophysiology of PCOS: A Literature Review
by: Abrar Alhermi, et al.
Published: (2025-01-01)

Non-alcoholic fatty liver disease – a rapidly growing indication for liver transplantation in the modern world
by: I. M. Iljinsky, et al.
Published: (2019-10-01)

New steatotic liver disease criteria diagnostic performance in an agricultural population in Chile
by: Maria Spencer-Sandino, et al.
Published: (2025-07-01)

Current and Emerging Treatments for Metabolic Associated Steatotic Liver Disease and Diabetes: A Narrative Review
by: Rachelle Choi, et al.
Published: (2025-06-01)

Is nonalcoholic fatty liver disease associated with metabolic syndrome? An experience from a medical college of West Bengal, India
by: Sounak Sinha, et al.
Published: (2025-06-01)

Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study
by: Woo-Young Shin, et al.
Published: (2025-04-01)

Associations between circulating amino acids and metabolic dysfunction‐associated steatotic liver disease in individuals living with severe obesity
by: Ina Maltais‐Payette, et al.
Published: (2025-02-01)

A bibliometric analysis of a decade’s research on metabolic dysfunction-associated steatotic liver disease in the Arab world
by: Waleed Alhazzani, et al.
Published: (2025-05-01)

Attenuation Based Quantitative Evaluation of Hepatic Steatosis Using US: Current Status and Future Perspective
by: Dong Ho Lee
Published: (2025-05-01)

Liver fibrosis progression analyzed with AI predicts renal decline
by: Dan-Qin Sun, et al.
Published: (2025-05-01)

Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
by: Yue Wang, et al.
Published: (2025-02-01)